|Place of Origin:||China|
|Certification:||COA, HPLC MR|
|Minimum Order Quantity:||1KG|
|Packaging Details:||Aluminum Bag or 25KG/Fibre Drum|
|Delivery Time:||3-5 work days after your payment|
|Payment Terms:||Western Union, T/T, MoneyGram|
|Name:||Medical Antibiotics Powder Cefixime For Bronchitis Treating CAS 79350-37-1||CAS:||79350-37-1|
|Shelf Life:||2 YEARS||Storage:||2~8 Centigrade|
What is Medical Antibiotics Powder Cefixime For Bronchitis Treating CAS 79350-37-1?
|Product Name||Medical Antibiotics Powder Cefixime for Bronchitis Treating CAS 79350-37-1|
|Storage||Keep in a cool, dry, dark location|
|Deliver Time||Within 24 Hours After Receiving The Payment|
Cefixime (Cefixime) is a third-generation cephalosporin antibiotic for oral use. It is suitable for the treatment of respiratory, urinary and biliary infections caused by sensitive bacteria. Cefixime is highly stable to β-lactamase produced by gram-negative bacilli. Its antibacterial effect on gram-negative bacilli is stronger than that of the first and second-generation cephalosporins, and its antibacterial effect on gram-positive cocci is not as good as that of the first and second-generation cephalosporins. The second generation cephalosporin.
Cefixime treats infections of the:
Ear: Otitis caused by Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes.
Throat: Tonsillitis, pharyngitis caused by Streptococcus pyogenes.
Chest and lungs: Bronchitis, pneumonia caused by Streptococcus pneumoniae and Haemophilus influenzae.
It is also used to treat typhoid fever.
Mechanism of action
The bactericidal action of Cefixime is due to the inhibition of cell wall synthesis. It binds to one of the penicillin binding proteins (PBPS) which inhibits the final transpeptidation step of the peptidoglycan synthesis in the bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.
Only 40-50% is absorbed from the GI tract (oral bioavailability). Absorption may be decreased when taken with food. Average peak concentration after administration of oral suspension is approximately 25-50% greater than the peak concentration following oral tablet or capsules administration.
It has high concentrations in bile and urine. It can cross the placenta and its protein binding capacity is 65%.
Cefixime is used to treat the following infections caused by sensitive bacteria:
1. Respiratory infections, such as bronchitis, pneumonia, etc.
2. Urinary system infection, such as pyelonephritis, cystitis, urethritis, etc.
3. Biliary tract infection, such as cholecystitis, cholangitis;
Package and Shipping of Medical Antibiotics Powder Cefixime For Bronchitis Treating CAS 79350-37-1